Targeted small molecule Stabilisation of Protein Protein Interactions
The goal of the TASPPI European Training Network (ETN) is the establishment of a highly interdisciplinary research and educational training platform for early stage scientists in the Chemical Life Sciences to overcome the inherent...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CHEMBIOMECH
Exploring mechanism in chemical biology by high throughput a...
564K€
Cerrado
DOS
Drugging the Undruggable Discovery of Protein Protein Inter...
1M€
Cerrado
CTQ2015-69643-R
DE FRAGMENTOS A HITS: APROVECHANDO EL POTENCIAL DE LA QUIMIC...
73K€
Cerrado
CHEMBIOHISTONE
Expanding the chemical biology toolkit for the studies of hi...
183K€
Cerrado
PID2021-122558OB-I00
DESARROLLO DE NUEVAS REACCIONES MULTICOMPONENTE PARA SU APLI...
115K€
Cerrado
BES-2014-068776
HERRAMIENTAS SINTETICAS EN QUIMICA BIOLOGICA. NUEVAS ESTRATE...
88K€
Cerrado
Información proyecto TASPPI
Duración del proyecto: 54 meses
Fecha Inicio: 2015-07-20
Fecha Fin: 2020-01-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The goal of the TASPPI European Training Network (ETN) is the establishment of a highly interdisciplinary research and educational training platform for early stage scientists in the Chemical Life Sciences to overcome the inherent boundaries between academia and industry and to increase their employability in both areas. To this end we have teamed up in a consortium comprising 5 partners from industry (AstraZeneca, GlaxoSmithKline, UCB, Lead Disocvery Center, Taros Chemicals) and 6 partners from academia (Universities of Dundee, Eindhoven, Leeds, Lille, Prague, and Siena). The scientific objective of the multi-sectorial Training Network is the development and implementation of a multidisciplinary technology platform bringing together structural molecular biology, chemical biology, cell biology, synthetic chemistry, and medicinal chemistry for the identification of Small-molecule Stabilizers of Protein-Protein Interactions (PPIs) as a novel class of therapeutic agents and basic research tool compounds. With this new technological approach we aim to address a number of unmet medical needs in the areas Cancer, Neurodegenerative Diseases (Alzheimer’s, Parkinson’s), Pulmonary Diseases, Inflammation and Metabolic Diseases (Diabetes).